Cargando…
A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification has categorized it as fibrin-associated large B-cell lymp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253260/ https://www.ncbi.nlm.nih.gov/pubmed/37297811 http://dx.doi.org/10.3390/jcm12113614 |
_version_ | 1785056363463835648 |
---|---|
author | Martin de Bustamante, Jose Manuel Mendoza, Ana López-Muñoz, Samuel García-Fernández, Eugenia Gómez-Prieto, Pilar Jiménez-Yuste, Victor |
author_facet | Martin de Bustamante, Jose Manuel Mendoza, Ana López-Muñoz, Samuel García-Fernández, Eugenia Gómez-Prieto, Pilar Jiménez-Yuste, Victor |
author_sort | Martin de Bustamante, Jose Manuel |
collection | PubMed |
description | Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification has categorized it as fibrin-associated large B-cell lymphomas (FA-LBCLs); therefore, it could be referred to as breast implant-associated fibrin-associated large B-cell lymphomas (BIA-FA-LBCLs). Although the association between breast implants and lymphomas has been known since the mid-1990s, it has been almost exclusively breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Here, we describe the first case of BIA-FA-LBCL at our center, with a literature review of the clinical features, diagnosis and treatment approach of this lymphoma. We also explore the differential diagnosis of BIA-FA-LBCL, highlighting the diagnostic challenges and the reasons that have led these lymphomas to being labeled as a new face of FA-LBCL. |
format | Online Article Text |
id | pubmed-10253260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102532602023-06-10 A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma Martin de Bustamante, Jose Manuel Mendoza, Ana López-Muñoz, Samuel García-Fernández, Eugenia Gómez-Prieto, Pilar Jiménez-Yuste, Victor J Clin Med Review Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification has categorized it as fibrin-associated large B-cell lymphomas (FA-LBCLs); therefore, it could be referred to as breast implant-associated fibrin-associated large B-cell lymphomas (BIA-FA-LBCLs). Although the association between breast implants and lymphomas has been known since the mid-1990s, it has been almost exclusively breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Here, we describe the first case of BIA-FA-LBCL at our center, with a literature review of the clinical features, diagnosis and treatment approach of this lymphoma. We also explore the differential diagnosis of BIA-FA-LBCL, highlighting the diagnostic challenges and the reasons that have led these lymphomas to being labeled as a new face of FA-LBCL. MDPI 2023-05-23 /pmc/articles/PMC10253260/ /pubmed/37297811 http://dx.doi.org/10.3390/jcm12113614 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Martin de Bustamante, Jose Manuel Mendoza, Ana López-Muñoz, Samuel García-Fernández, Eugenia Gómez-Prieto, Pilar Jiménez-Yuste, Victor A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma |
title | A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma |
title_full | A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma |
title_fullStr | A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma |
title_full_unstemmed | A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma |
title_short | A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma |
title_sort | new face of fibrin-associated large b-cell lymphoma: epstein–barr virus-positive breast implant-associated diffuse large b-cell lymphoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253260/ https://www.ncbi.nlm.nih.gov/pubmed/37297811 http://dx.doi.org/10.3390/jcm12113614 |
work_keys_str_mv | AT martindebustamantejosemanuel anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT mendozaana anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT lopezmunozsamuel anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT garciafernandezeugenia anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT gomezprietopilar anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT jimenezyustevictor anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT martindebustamantejosemanuel newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT mendozaana newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT lopezmunozsamuel newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT garciafernandezeugenia newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT gomezprietopilar newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma AT jimenezyustevictor newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma |